Ellis Sean 4

What Happened
Sean Ellis, a director of Entera Bio Ltd. (ENTX), made an open-market purchase of 18,000 ordinary shares on February 9, 2026. The reported weighted average purchase price was $1.24 per share, for a total cost of approximately $22,320. The filing lists the transaction as a purchase (code P) and notes multiple executions at prices ranging from $1.18 to $1.299.

Key Details

• Transaction date: 2026-02-09 (reported on Form 4 dated 2026-02-11) — appears timely (within the typical two-business-day reporting window).
• Quantity and price: 18,000 shares at a weighted average price of $1.24; execution prices ranged $1.18–$1.299 (see footnote).
• Approximate value: $22,320.
• Shares owned after transaction: Not disclosed in the provided excerpt of the filing.
• Footnote: The reported price is a weighted average; the filer offers to provide a breakdown of the number of shares bought at each price in the stated range upon request.
• Transaction type: Open market purchase (insider buy).

Context
Insider purchases can be of interest to retail investors as one data point of insider activity, but this purchase is relatively modest in dollar terms (~$22k). There is no indication of option exercises, awards, or gifts in this filing—just an open-market buy by a company director.